It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
KYKOF’s FA Score shows that 2 FA rating(s) are green whileOPHLY’s FA Score has 3 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
KYKOF’s TA Score shows that 4 TA indicator(s) are bullish while OPHLY’s TA Score has 6 bullish TA indicator(s).
KYKOF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while OPHLY (@Pharmaceuticals: Major) price change was +2.67% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.43%. For the same industry, the average monthly price growth was +6.77%, and the average quarterly price growth was +13.43%.
OPHLY is expected to report earnings on Oct 30, 2025.
The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
KYKOF | OPHLY | KYKOF / OPHLY | |
Capitalization | 10.4B | 9.03B | 115% |
EBITDA | 83.6B | 162B | 52% |
Gain YTD | 14.200 | 10.345 | 137% |
P/E Ratio | 29.33 | 11.40 | 257% |
Revenue | 404B | 447B | 90% |
Total Cash | 347B | 164B | 212% |
Total Debt | 5.55B | 9.17B | 60% |
KYKOF | OPHLY | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 28 | 17 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 23 Undervalued | 4 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 20 | |
PRICE GROWTH RATING 1..100 | 45 | 50 | |
P/E GROWTH RATING 1..100 | 7 | 10 | |
SEASONALITY SCORE 1..100 | 55 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
OPHLY's Valuation (4) in the null industry is in the same range as KYKOF (23). This means that OPHLY’s stock grew similarly to KYKOF’s over the last 12 months.
OPHLY's Profit vs Risk Rating (100) in the null industry is in the same range as KYKOF (100). This means that OPHLY’s stock grew similarly to KYKOF’s over the last 12 months.
OPHLY's SMR Rating (20) in the null industry is significantly better than the same rating for KYKOF (100). This means that OPHLY’s stock grew significantly faster than KYKOF’s over the last 12 months.
KYKOF's Price Growth Rating (45) in the null industry is in the same range as OPHLY (50). This means that KYKOF’s stock grew similarly to OPHLY’s over the last 12 months.
KYKOF's P/E Growth Rating (7) in the null industry is in the same range as OPHLY (10). This means that KYKOF’s stock grew similarly to OPHLY’s over the last 12 months.
KYKOF | OPHLY | |
---|---|---|
RSI ODDS (%) | 1 day ago30% | 1 day ago72% |
Stochastic ODDS (%) | 1 day ago45% | 1 day ago60% |
Momentum ODDS (%) | 1 day ago33% | 1 day ago60% |
MACD ODDS (%) | 1 day ago32% | 1 day ago54% |
TrendWeek ODDS (%) | 1 day ago27% | 1 day ago52% |
TrendMonth ODDS (%) | 1 day ago29% | 1 day ago50% |
Advances ODDS (%) | N/A | 3 days ago51% |
Declines ODDS (%) | N/A | 22 days ago64% |
BollingerBands ODDS (%) | 1 day ago60% | 1 day ago77% |
Aroon ODDS (%) | 1 day ago38% | 1 day ago53% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EMLP | 38.05 | 0.09 | +0.24% |
First Trust North Amer Engy InfrasETF | |||
WTPI | 32.36 | -0.06 | -0.19% |
WisdomTree Equity Premium Income Fund | |||
SRS | 47.64 | -0.44 | -0.92% |
ProShares UltraShort Real Estate | |||
IEO | 86.63 | -0.84 | -0.96% |
iShares US Oil & Gas Explor & Prod ETF | |||
FNGG | 215.26 | -3.00 | -1.38% |
Direxion Daily NYSE FANG+ Bull 2X Shares |
A.I.dvisor tells us that KYKOF and OPHLY have been poorly correlated (+12% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KYKOF and OPHLY's prices will move in lockstep.
Ticker / NAME | Correlation To KYKOF | 1D Price Change % | ||
---|---|---|---|---|
KYKOF | 100% | N/A | ||
OPHLY - KYKOF | 12% Poorly correlated | -0.45% | ||
NVSEF - KYKOF | 7% Poorly correlated | N/A | ||
GIKLY - KYKOF | 4% Poorly correlated | N/A | ||
MAYNF - KYKOF | -1% Poorly correlated | N/A | ||
HAWPF - KYKOF | -1% Poorly correlated | N/A | ||
More |
A.I.dvisor indicates that over the last year, OPHLY has been loosely correlated with OTSKY. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if OPHLY jumps, then OTSKY could also see price increases.
Ticker / NAME | Correlation To OPHLY | 1D Price Change % | ||
---|---|---|---|---|
OPHLY | 100% | -0.45% | ||
OTSKY - OPHLY | 42% Loosely correlated | +0.46% | ||
ALPMY - OPHLY | 36% Loosely correlated | +0.67% | ||
CHGCY - OPHLY | 26% Poorly correlated | -19.99% | ||
BAYRY - OPHLY | 22% Poorly correlated | +2.07% | ||
OPHLF - OPHLY | 14% Poorly correlated | N/A | ||
More |